Belgium· BE-AMP-SAM143157-00

Cymevene 500 mg

A ganciclovir product containing ganciclovir sodium, registered in Belgium by Cheplapharm Arzneimittel. The same ATC class is registered in 13 of our 19 countries.

ATC J05AB06

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ganciclovir sodiumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ganciclovir is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AB06 (ganciclovir), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
7 of them publish a price we can compare per daily dose

Search ganciclovir products by name

Ganciclovir · ATC J05AB06

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ganciclovir costs, country by country.

Normalised to the WHO defined daily dose (3 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Ganciclovir · price per daily dose (3 g)

USD · FX 28 Sept 2026

CH Switzerland$494.50

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Ganciclovir Sodium
Manufacturer: Cheplapharm Arzneimittel
Country: Belgium (BE)
ATC code: J05AB06
ATC class: Ganciclovir
Defined daily dose: 3 g, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
0731935
be_apb
2462471

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

277 interactions on record for ganciclovir.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check ganciclovir against other medicines How interaction checks work

Ganciclovir · interactions on record

277 records

8 severe
194 moderate
75 info

Most severe, free to view

CladribineL01BB04severe
TrospiumA03AB20moderate
Amphotericin BA07AA07moderate
NitisinoneA16AX04moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ganciclovir in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ganciclovir products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

Austria · Cymevene, Ganciclovir Oresund Pharma
Bulgaria · Ганцикловир Ромфарм
Czechia · Cymevene, Virgan
Germany · Cymeven I.V., Ganciclovir Accord
Denmark · Cymevene, Ganciclovir Oresund Pharma
Spain · Cymevene, Ganciclovir Accord
Finland · Cymevene, Ganciclovir Bioglan
France · Cymevan, Ganciclovir Hikma
United Kingdom (Northern Ireland) · Cymevene, Ganciclovir Kensington Pharma
Greece · Gancilen, Virgan
Croatia · Cymevene
Hungary · Cymevene, Ganciclovir Rompharm
Ireland · Cymevene
Italy · Citovirax, Ganciclovir Accord
Luxembourg · Cymevene, Virgan
Netherlands · Cymevene, Ganciclovir Sandoz
Norway · Cymevene, Ganciclovir Bioglan
Poland · Cymevene, Ganciclovir Accord
Portugal · Cymevene, Ganciclovir Accord
Romania · Ganciclovir Rompharm, Virgan
Sweden · Cymevene, Ganciclovir Bioglan
Slovakia · Cymevene

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/4437fc61-aa39-4a68-87ad-b52889f650a1
GET /v1/drugs/4437fc61-aa39-4a68-87ad-b52889f650a1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Cymevene 500 mg",
  "name_fr": "Cymevene 500 mg",
  "name_nl": "Cymevene 500 mg",
  "amp_code": "SAM143157-00",
  "strengths": [
    "546.0000",
    "500.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Ganciclovir Sodium",
    "Ganciclovir"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ganciclovir",
  "authorisation_numbers": [
    "BE143157"
  ]
}

API reference MCP server Plans

See everything about ganciclovir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console